Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03305042 · ClinicalTrials.gov registry record

Vitamin A Liver Reserves and Serum Markers of Vitamin A in US Adults at Time of Death

A clinical trial, sponsored by University of Wisconsin, Madison.

Completed
Registry status
27
Enrollment target

NCT03305042 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 27 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03305042 has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
27 participants
Enrollment target

Study Summary

Minimal human data exist on actual liver vitamin A compared with blood biomarkers. One blood biomarker, the percent of total serum retinol (vitamin A) in the form of retinyl esters, has been suggested to diagnose hypervitaminosis A with cutoffs of 5% and 10%. In this study, investigators aim to compare total liver vitamin A reserves with the percent total serum retinol as retinyl esters to evaluate hypervitaminosis A using autopsy samples from US adults. Investigators also evaluate the sensitivity (the ability of the biomarker to correctly identify those with deficiency) and specificity (the ability of the biomarker to correctly identify those without deficiency) of serum retinol to determine vitamin A deficiency, variation of liver vitamin A concentration among lobes, and liver alpha retinyl ester concentrations, a cleavage product of alpha-carotene, a vitamin A precursor. To conduct the study, matched serum and liver samples were procured from 27 US adult cadavers (from donors age 49-101 years) and their vitamin A biomarkers were analyzed.

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2012-02-01
Est. Completion 2017-01-31

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT03305042

The ClinicalTrials.gov registry entry for NCT03305042 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03305042 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03305042 about?

NCT03305042 is a clinical study titled "Vitamin A Liver Reserves and Serum Markers of Vitamin A in US Adults at Time of Death". Minimal human data exist on actual liver vitamin A compared with blood biomarkers. One blood biomarker, the percent of total serum retinol (vitamin A) in the form of retinyl esters, has been suggested to diagnose hypervitaminosis A with cutoffs of 5% and 10%. In this study, investigators aim to comp...

What is the current status of trial NCT03305042?

This trial is currently completed. The enrollment target is 27 participants. The study started on 2012-02-01. Estimated completion is 2017-01-31.

Who is sponsoring clinical trial NCT03305042?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.